三角神经疼痛中医疗管理和微血管减压的五年前景结果
Jacob Worm1,2, Tone Bruvik Heinskou3, Per Rochat4,5
1Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Valdemar Hansens Vej 5, 2600, Glostrup, Denmark. jacob.worm@regionh.dk.
Journal of neurology
|October 16, 2025
概括
与医疗管理相比,微血管减压 (MVD) 为三角神经疼痛提供了优越的5年缓解疼痛. MVD显著增加了无药性疼痛自由,支持早期的手术考虑.
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 疼痛管理 疼痛管理
背景情况:
- 三神经疼痛 (TN) 是一种使人虚弱的面部疼痛状况,影响生活质量.
- 有限的长期数据存在,比较TN的医疗治疗和微血管减压 (MVD).
- 这项研究调查了TN患者的5年治疗结果和治疗反应预测因素.
研究的目的:
- 为了比较医疗管理与三角神经疼痛中MVD的5年疗效.
- 在TN患者中确定成功治疗结果的预测因素.
- 为了评估无药物疼痛缓解率和与治疗有关的副作用.
主要方法:
- 在国家推中心进行前性观察队列研究 (2012-2019).
- 包括连续患有经典或异常性三角神经疼痛的患者.
- 系统的5年随访评估疼痛状态和治疗分配 (医疗与MVD) 基于指导方针.
主要成果:
- 微血管减压 (MVD) 与医疗治疗相比,在没有药物的情况下实现了明显更高的无疼痛率 (59%对19%).
- 在药物治疗中,MVD导致持续疼痛的频率较低 (22%对49%).
- 男性性别是MVD (OR2.60) 后优秀结果的预测因素.
结论:
- 与医疗管理相比,微血管减压 (MVD) 在三角神经疼痛方面表现出优异的长期疼痛缓解和无药物治疗结果.
- 结果支持在选择的TN患者中早期考虑对MVD进行手术.
- 基于指导方针的个性化护理对于优化三角神经疼痛治疗结果至关重要.
相关概念视频
01:26Mitral Stenosis III: Medical Management
245
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
245
01:25Mitral Regurgitation III: Medical Management
274
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
274
01:27Open Angle Glaucoma: Treatment
958
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
958
01:25Aortic Regurgitation III: Medical Management
392
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
392
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K